Verano Holdings Corp. (VRNOF)
(Delayed Data from OTC)
$3.84 USD
-0.06 (-1.54%)
Updated Aug 2, 2024 12:33 PM ET
4-Sell of 5 4
B Value B Growth B Momentum A VGM
Brokerage Reports
Verano Holdings Corp. [VRNOF]
Reports for Purchase
Showing records 1 - 20 ( 145 total )
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
1Q24 Mixed, Margins Remain Strong Generating Cash Flow
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Solid Q124 Print, Verano Awaiting Federal and State Catalysts Before Deciding What to Do with its War Chest
Provider: Echelon Welath Partners
Analyst: SEMPLE A
Company: Verano Holdings Corp.
Industry: Medical - Products
Cannabis ReHash: DEA Intends to Move to Schedule 3, Investors Not Pricing It In
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
US Cannabis Sector - The Smoke has Lifted! DEA Appears Poised to Publish Schedule III Ruling
Provider: Echelon Welath Partners
Analyst: Research Department
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
Consumer -36th Annual ROTH Conference Health Wellness Takeaways
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
Due to an analyst departure, we are discontinuing coverage.
Provider: VENTUM CAPITAL MARKETS
Analyst: Research Department
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: February Performance and Valuations
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
4Q23 In-line, NJ Pause But Catalyst In Place To Generate CF
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Solid Q423 Results Though a Soft Q1 Guide. Underlying Growth Trends Remain Positive with State Catalysts to Drive Upside.
Provider: Echelon Welath Partners
Analyst: SEMPLE A
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: U.S. Cannabis 4Q23 Earnings Week I
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S